1mhe

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
The crystal structure of the nonclassical human class lb MHC molecule, HLA-E has been determined in complex with a prototypic ligand, the nonamer, peptide (VMAPRTVLL), derived from the highly conserved residues 3-11 of, the human MHC class la leader sequence. The mode of peptide binding, retains some of the standard features observed in MHC class la complexes, but novel features imply that HLA-E has evolved to mediate specific, binding to a tightly defined set of almost identical hydrophobic peptides, from the highly conserved class l leader sequences. These molecular, adaptations make HLA-E a rigorous checkpoint at the cell surface reporting, on the integrity of the antigen processing pathway to CD94/NKG2, receptor-bearing natural killer cells.
+
The crystal structure of the nonclassical human class lb MHC molecule HLA-E has been determined in complex with a prototypic ligand, the nonamer peptide (VMAPRTVLL), derived from the highly conserved residues 3-11 of the human MHC class la leader sequence. The mode of peptide binding retains some of the standard features observed in MHC class la complexes, but novel features imply that HLA-E has evolved to mediate specific binding to a tightly defined set of almost identical hydrophobic peptides from the highly conserved class l leader sequences. These molecular adaptations make HLA-E a rigorous checkpoint at the cell surface reporting on the integrity of the antigen processing pathway to CD94/NKG2 receptor-bearing natural killer cells.
==Disease==
==Disease==
Line 16: Line 16:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Protein complex]]
[[Category: Protein complex]]
-
[[Category: Bell, J.I.]]
+
[[Category: Bell, J I.]]
-
[[Category: Braud, V.B.]]
+
[[Category: Braud, V B.]]
-
[[Category: Callaghan, C.A.O.]]
+
[[Category: Callaghan, C A.O.]]
-
[[Category: Jakobsen, B.K.]]
+
[[Category: Jakobsen, B K.]]
-
[[Category: Jones, E.Y.]]
+
[[Category: Jones, E Y.]]
-
[[Category: Mcmichael, A.J.]]
+
[[Category: Mcmichael, A J.]]
-
[[Category: Stuart, D.I.]]
+
[[Category: Stuart, D I.]]
[[Category: Tormo, J.]]
[[Category: Tormo, J.]]
-
[[Category: Willcox, B.E.]]
+
[[Category: Willcox, B E.]]
[[Category: SO4]]
[[Category: SO4]]
[[Category: beta 2 microglobulin]]
[[Category: beta 2 microglobulin]]
Line 37: Line 37:
[[Category: peptide]]
[[Category: peptide]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 16:24:19 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:55:16 2008''

Revision as of 11:55, 21 February 2008


1mhe, resolution 2.85Å

Drag the structure with the mouse to rotate

THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E

Contents

Overview

The crystal structure of the nonclassical human class lb MHC molecule HLA-E has been determined in complex with a prototypic ligand, the nonamer peptide (VMAPRTVLL), derived from the highly conserved residues 3-11 of the human MHC class la leader sequence. The mode of peptide binding retains some of the standard features observed in MHC class la complexes, but novel features imply that HLA-E has evolved to mediate specific binding to a tightly defined set of almost identical hydrophobic peptides from the highly conserved class l leader sequences. These molecular adaptations make HLA-E a rigorous checkpoint at the cell surface reporting on the integrity of the antigen processing pathway to CD94/NKG2 receptor-bearing natural killer cells.

Disease

Known disease associated with this structure: Hypoproteinemia, hypercatabolic OMIM:[109700]

About this Structure

1MHE is a Protein complex structure of sequences from Homo sapiens with as ligand. Full crystallographic information is available from OCA.

Reference

Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E., O'Callaghan CA, Tormo J, Willcox BE, Braud VM, Jakobsen BK, Stuart DI, McMichael AJ, Bell JI, Jones EY, Mol Cell. 1998 Mar;1(4):531-41. PMID:9660937

Page seeded by OCA on Thu Feb 21 13:55:16 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools